{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T04:58:47Z","timestamp":1755925127421},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6794,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1023\/a:1011160110205","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T11:26:45Z","timestamp":1040642805000},"page":"767-772","source":"Crossref","is-referenced-by-count":20,"title":["Cisplatin and vinorelbine in advanced and\/or metastatic adenocarcinoma of the endometrium: A new highly active chemotherapeutic regimen"],"prefix":"10.1016","volume":"12","author":[{"given":"V.","family":"Gebbia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Testa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Borsellino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ferrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tirrito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Palmeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1011160110205_bb0010","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00001622-199210000-00016","article-title":"Risk factors, epidemiology, screening, and prognostic factors in female genital cancer","volume":"4","author":"Friedlander","year":"1992","journal-title":"Curr Opin Oncol"},{"key":"10.1023\/A:1011160110205_bb0015","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0002-9378(11)80012-8","article-title":"Reproductive factors and risk of endometrial cancer","volume":"164","author":"Parazzini","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1023\/A:1011160110205_bb0020","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1200\/JCO.1991.9.6.1071","article-title":"Systemic treatment of advanced and recurrent endometrial carcinoma: Current status and future directions","volume":"9","author":"Moore","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011160110205_bb0025","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/00001622-199210000-00019","article-title":"Systemic therapy for gynecological cancer","volume":"4","author":"Markman","year":"1992","journal-title":"Curr Opin Oncol"},{"key":"10.1023\/A:1011160110205_bb0030","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00001622-199409000-00015","article-title":"Advances in the chemotherapy of gynecological cancer","volume":"6","author":"Neijt","year":"1994","journal-title":"Curr Opin Oncol"},{"key":"10.1023\/A:1011160110205_bb0035","first-page":"21","article-title":"Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study","volume":"63","author":"Thigpen","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1023\/A:1011160110205_bb0040","first-page":"159","article-title":"Comparison of adriamycin with cyclophosphamide in patients with advanced endometrial cancer","volume":"62","author":"Horton","year":"1978","journal-title":"Cancer Treat Rep"},{"issue":"Suppl","key":"10.1023\/A:1011160110205_bb0045","first-page":"10","article-title":"Phase II evaluation of epirubicin (E) in advanced endometrial carcinoma","volume":"1","author":"Calero","year":"1990","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1011160110205_bb0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0090-8258(80)90062-1","article-title":"Treatment of advanced endometrial adenocarcinoma with cis-dichlorodiammine platinum (II) after intensive prior therapy","volume":"10","author":"Deppe","year":"1980","journal-title":"Gynecol Oncol"},{"key":"10.1023\/A:1011160110205_bb0055","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/jnci\/80.4.276","article-title":"Phase II evaluation of carboplatin in advanced endometrial carcinoma","volume":"80","author":"Long","year":"1988","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1011160110205_bb0060","first-page":"115","article-title":"A randomized comparison of adriamycin with or without cyclophosphamide in the treatment of advanced or recurrent endometrial carcinoma","volume":"4","author":"Thigpen","year":"1985","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"Suppl","key":"10.1023\/A:1011160110205_bb0065","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1007\/BF00685407","article-title":"A phase II study of ifosfamide in endometrial cancer","volume":"26","author":"Barton","year":"1990","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1023\/A:1011160110205_bb0070","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0090-8258(90)90289-W","article-title":"Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide","volume":"40","author":"Burke","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1023\/A:1011160110205_bb0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0090-8258(91)90268-A","article-title":"Treatment of advanced and recurrent endometrial cancer with cisplatin, doxorubicin, and cyclophosphamide","volume":"41","author":"Dunton","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1023\/A:1011160110205_bb0080","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00000421-199106000-00006","article-title":"Phase II trial of cisplatin, adriamycin and etoposide for metastatic endometrial adenocarcinoma","volume":"14","author":"Piver","year":"1991","journal-title":"Am J Clin Oncol"},{"key":"10.1023\/A:1011160110205_bb0085","first-page":"261","article-title":"Phase III trial of doxorubicin with or without cisplatin in advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group Study","volume":"12","author":"Thigpen","year":"1993","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1023\/A:1011160110205_bb0090","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.1996.0227","article-title":"A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: A Gynecologic Oncology Group study","volume":"62","author":"Ball","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1023\/A:1011160110205_bb0095","first-page":"78","article-title":"A trial of outpatient paclitaxel and carboplatin for advanced, recurrent, and histological high-risk endometrial carcinoma: Preliminary report","volume":"24","author":"Price","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1011160110205_bb0100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0305-7372(96)90032-8","article-title":"Vinorelbine: An overview","volume":"22","author":"Johnson","year":"1996","journal-title":"Cancer Treat Rev"},{"key":"10.1023\/A:1011160110205_bb0105","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1200\/JCO.1993.11.7.1245","article-title":"Phase II trial of weekly intravenous vinorelbine on first line advanced breast cancer chemotherapy","volume":"11","author":"Fumoleau","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011160110205_bb0110","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1200\/JCO.1994.12.2.360","article-title":"Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non small cell lung cancer","volume":"13","author":"Le Chevalier","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011160110205_bb0115","first-page":"1247","article-title":"Vinorelbine plus cisplatin for the treatment of stage IIIB and IV non-small cell lung cancer","volume":"14","author":"Gebbia","year":"1994","journal-title":"Anticancer Res"},{"key":"10.1023\/A:1011160110205_bb0120","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/0959-8049(93)90095-W","article-title":"A pilot study of vinorelbine on a weekly schedule in recurrent and\/or metastatic squamous cell carcinoma of the head and neck","volume":"29A","author":"Gebbia","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1023\/A:1011160110205_bb0125","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/oxfordjournals.annonc.a059095","article-title":"Treatment of recurrent and\/or metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin and 5-fluorouracil: A multicenter phase II trial","volume":"6","author":"Gebbia","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1011160110205_bb0130","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1394::AID-CNCR17>3.0.CO;2-V","article-title":"Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck","volume":"79","author":"Gebbia","year":"1997","journal-title":"Cancer"},{"key":"10.1023\/A:1011160110205_bb0135","first-page":"268","article-title":"Phase II study vinorelbine in advanced squamous cell carcinoma of the uterine cervix (SCC): Preliminary results","volume":"14","author":"Morris","year":"1995","journal-title":"Proc Am Ass Clin Oncol"},{"key":"10.1023\/A:1011160110205_bb0140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1023\/A:1011160110205_bb0145","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1959","journal-title":"J Am Stat Assoc"},{"key":"10.1023\/A:1011160110205_bb0150","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0021-9681(61)90060-1","article-title":"The determination of the number of patients required in a preliminary trial and a follow-up trial of a new chemotherapeutic agent","volume":"13","author":"Gehan","year":"1961","journal-title":"J Chron Dis"},{"key":"10.1023\/A:1011160110205_bb0155","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1200\/JCO.1999.17.3.756","article-title":"Phase II study of cisplatin and vinorelbine as first-line chemotherapy of patients with carcinoma of the uterine cervix","volume":"17","author":"Pignata","year":"1999","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419479738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419479738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/12\/6\/767\/19479275\/12-6-767.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T06:58:43Z","timestamp":1582181923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419479738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S0923753419479738"],"URL":"https:\/\/doi.org\/10.1023\/a:1011160110205","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}